BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10
13 results:

  • 1. LncRNA CEBPA-DT promotes liver cancer metastasis through ddr2/β-catenin activation via interacting with hnRNPC.
    Cai Y; Lyu T; Li H; Liu C; Xie K; Xu L; Li W; Liu H; Zhu J; Lyu Y; Feng X; Lan T; Yang J; Wu H
    J Exp Clin Cancer Res; 2022 Dec; 41(1):335. PubMed ID: 36471363
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hepatoid prostatic carcinoma with adrenal metastasis and novel genetic alterations.
    Ayala Soriano C; Benitez Barzaga M; Chhina A; Jain M; Nava VE
    Diagn Cytopathol; 2022 Nov; 50(11):E310-E314. PubMed ID: 35765767
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The portrait of liver cancer is shaped by mitochondrial genetics.
    Chattopadhyay M; Jenkins EC; Lechuga-Vieco AV; Nie K; Fiel MI; Rialdi A; Guccione E; Enriquez JA; Sia D; Lujambio A; Germain D
    Cell Rep; 2022 Jan; 38(3):110254. PubMed ID: 35045282
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma.
    Chen Y; Wang X; Deng X; Zhang Y; Liao R; Li Y; Yang H; Chen K
    Front Immunol; 2021; 12():676922. PubMed ID: 34335575
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Amplification of ddr2 mediates sorafenib resistance through NF-κB/c-Rel signaling in hepatocellular carcinoma.
    Liu QQ; Liu YW; Xie YK; Zhang JH; Song CX; Wang JZ; Xie BH
    Cell Biol Int; 2021 Sep; 45(9):1906-1916. PubMed ID: 33969575
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor ddr2.
    Slocum E; Craig A; Villanueva A; Germain D
    Breast Cancer Res; 2019 May; 21(1):56. PubMed ID: 31046834
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
    Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ddr2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.
    Xie B; Lin W; Ye J; Wang X; Zhang B; Xiong S; Li H; Tan G
    J Exp Clin Cancer Res; 2015 Sep; 34(1):101. PubMed ID: 26362312
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma.
    Park JW; Lee YS; Kim JS; Lee SK; Kim BH; Lee JA; Lee NO; Kim SH; Hong EK
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1973-83. PubMed ID: 25842034
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2.
    Lee NO; Park JW; Lee JA; Shim JH; Kong SY; Kim KT; Lee YS
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):73-84. PubMed ID: 22009181
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.
    Badiola I; Villacé P; Basaldua I; Olaso E
    Oncol Rep; 2011 Oct; 26(4):971-8. PubMed ID: 21701781
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Switching in discoid domain receptor expressions in SLUG-induced epithelial-mesenchymal transition.
    Maeyama M; Koga H; Selvendiran K; Yanagimoto C; Hanada S; Taniguchi E; Kawaguchi T; Harada M; Ueno T; Sata M
    Cancer; 2008 Nov; 113(10):2823-31. PubMed ID: 18853422
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epidemiology of hepatocellular carcinoma in a province of northern Italy: prevalence of the risk factors and incidence in the population.
    Mels GC; Leandro G; Scorpiniti A; Cristini P; Moretti GB; Di Nolfo AM; Angeli G
    Tumori; 1993 Feb; 79(1):16-21. PubMed ID: 8388587
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.